E

Elanco Animal Health
D

ELAN

14.670
USD
-0.06
(-0.37%)
مغلق
حجم التداول
55,476
الربح لكل سهم
1
العائد الربحي
-
P/E
20
حجم السوق
7,285,804,214
أصول ذات صلة
ABBV
ABBV
-1.530
(-0.80%)
189.200 USD
AMGN
AMGN
1.79
(0.60%)
298.52 USD
A
AUPH
0.09000
(1.20%)
7.57000 USD
BIIB
BIIB
-1.170
(-0.88%)
132.000 USD
BMY
BMY
-0.525
(-1.10%)
47.080 USD
CAH
CAH
3.340
(2.06%)
165.200 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
I
INO
-0.71500
(-33.49%)
1.42000 USD
المزيد
الأخبار المقالات

العنوان: Elanco Animal Health

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal productsused in cattle, sheep, goats, and swine production.